Skip to content

Clinical evaluation and correlation study of peripheral neuropathy in patients with cirrhosis

Clinical evaluation and correlation study of peripheral neuropathy in patients with cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064939
Enrollment
Unknown
Registered
2022-10-24
Start date
2022-10-24
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cirrhosis

Interventions

Group 1:
Group 2:

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. Clinically diagnosed as liver cirrhosis; 3. Able to clearly understand the test instructions; 4. Understand and be willing to participate in this clinical trial and provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Metabolic diseases, such as diabetes mellitus (DM); 2. Central nervous system diseases, such as overt hepatic encephalopathy, stroke or Parkinson's disease; 3. Other causes of neuropathy, such as toxin or drug exposure; 4. Cervical spondylosis or lumbar spondylosis; 5. Limb injury; 6. There are skin lesions at the detection site; 7. Renal damage (elevated serum creatinine); 8. Malignant tumors.

Design outcomes

Primary

MeasureTime frame
CPT value;albumin;aspartate aminotransferase;alanine aminotransferase;total bilirubin;alkaline phosphatase;prothrombin time;

Countries

China

Contacts

Public ContactNannan Zhang

The First Affiliated Hospital of Fujian Medical University

819046847@qq.com+8618860103739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026